De Fanti Sara, Vicario Saverio, Lang Martin, Simone Domenico, Magli Cristina, Luiselli Donata, Gianaroli Luca, Romeo Giovanni
Department of Biological, Geological and Environmental Sciences, University of Bologna, Bologna 40126, Italy.
Institute of Atmospheric Pollution Research, National Research Council, C/O Physics Department, University of Bari 'Aldo Moro', Bari 70132, Italy.
Hum Reprod. 2017 May 1;32(5):1100-1107. doi: 10.1093/humrep/dex051.
Does selection for mtDNA mutations occur in human oocytes?
We provide statistical evidence in favor of the existence of purifying selection for mtDNA mutations in human oocytes acting between the expulsion of the first and second polar bodies (PBs).
Several lines of evidence in Metazoa, including humans, indicate that variation within the germline of mitochondrial genomes is under purifying selection. The presence of this internal selection filter in the germline has important consequences for the evolutionary trajectory of mtDNA. However, the nature and localization of this internal filter are still unclear while several hypotheses are proposed in the literature.
STUDY DESIGN, SIZE, DURATION: In this study, 60 mitochondrial genomes were sequenced from 17 sets of oocytes, first and second PBs, and peripheral blood taken from nine women between 38 and 43 years of age.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Whole genome amplification was performed only on the single cell samples and Sanger sequencing was performed on amplicons. The comparison of variant profiles between first and second PB sequences showed no difference in substitution rates but displayed instead a sharp difference in pathogenicity scores of protein-coding sequences using three different metrics (MutPred, Polyphen and SNPs&GO).
Unlike the first, second PBs showed no significant differences in pathogenic scores with blood and oocyte sequences. This suggests that a filtering mechanism for disadvantageous variants operates during oocyte development between the expulsion of the first and second PB.
N/A.
LIMITATIONS, REASONS FOR CAUTION: The sample size is small and further studies are needed before this approach can be used in clinical practice. Studies on a model organism would allow the sample size to be increased.
This work opens the way to the study of the correlation between mtDNA mutations, mitochondrial capacity and viability of oocytes.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a SISMER grant. Laboratory facilities and skills were freely provided by SISMER, and by the Alma Mater Studiorum, University of Bologna. The authors have no conflict of interest to disclose.
人类卵母细胞中是否存在线粒体DNA(mtDNA)突变的选择?
我们提供了统计学证据,支持在人类卵母细胞中,从第一极体(PB)排出到第二极体排出之间存在针对mtDNA突变的纯化选择。
包括人类在内的后生动物的几条证据表明,线粒体基因组种系内的变异处于纯化选择之下。种系中这种内部选择过滤器的存在对mtDNA的进化轨迹具有重要影响。然而,这种内部过滤器的性质和定位仍不清楚,同时文献中提出了几种假设。
研究设计、规模、持续时间:在本研究中,对17组卵母细胞、第一极体和第二极体以及从9名38至43岁女性采集的外周血中的60个线粒体基因组进行了测序。
参与者/材料、环境、方法:仅对单细胞样本进行全基因组扩增,并对扩增子进行桑格测序。第一极体和第二极体序列之间的变异谱比较显示,替换率没有差异,但使用三种不同指标(MutPred、Polyphen和SNPs&GO)对蛋白质编码序列的致病性评分显示出明显差异。
与第一极体不同,第二极体在致病性评分上与血液和卵母细胞序列没有显著差异。这表明在第一极体和第二极体排出之间的卵母细胞发育过程中,存在一种针对不利变异的过滤机制。
无。
局限性、谨慎原因:样本量较小,在该方法可用于临床实践之前,还需要进一步研究。对模式生物的研究将使样本量增加。
这项工作为研究mtDNA突变、线粒体能力和卵母细胞活力之间的相关性开辟了道路。
研究资金/利益冲突:这项工作得到了SISMER基金的支持。实验室设施和技术由SISMER以及博洛尼亚大学阿尔马·斯图迪奥尔姆自由提供。作者没有利益冲突需要披露。